Colon cancer stem cells: Implications in carcinogenesis

Frontiers in Bioscience

Volumn 16, Issue 5, 2011, Pages 1651-1662

  Sanders, Matthew A ^a,b   Majumdar, Adhip P N ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta catenin; CD133; CD44; Crypt; Differentiation; Integrin; Intestinal epithelial cell; Review; Small intestine; Stem cell

Indexed keywords

ABC TRANSPORTER; ALCAM PROTEIN, HUMAN; ALDEHYDE DEHYDROGENASE; ALDH1A1 PROTEIN, HUMAN; CD133 ANTIGEN; FETOPROTEIN; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; HERMES ANTIGEN; LEUKOCYTE ANTIGEN; LGR5 PROTEIN, HUMAN; NERVE CELL ADHESION MOLECULE; PEPTIDE; TUMOR MARKER;

ANIMAL; CANCER STEM CELL; COLON TUMOR; METABOLISM; MOUSE; PATHOLOGY; PROGNOSIS; REVIEW; STEM CELL;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ATP-BINDING CASSETTE TRANSPORTERS; CELL ADHESION MOLECULES, NEURONAL; COLONIC NEOPLASMS; FETAL PROTEINS; GLYCOPROTEINS; MICE; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS; RECEPTORS, G-PROTEIN-COUPLED; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 79954987871     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3811     Document Type: Article

References (110)

1. Jemal, A., M.M. Center, E. Ward, & M.J. Thun: Cancer occurrence. Methods Mol Biol 471, 3-29 (2009)
2. Welch, J.P. & G.A. Donaldson: The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 189, 496-502 (1979) (Pubitemid 9172343)
3. Dick, J.E.: Stem cell concepts renew cancer research. Blood 112, 4793-807 (2008)
4. Reya, T., S.J. Morrison, M.F. Clarke, & I.L. Weissman: Stem cells, cancer, and cancer stem cells. Nature 414, 105-11 (2001) (Pubitemid 33041634)
5. Wang, J.C. & J.E. Dick: Cancer stem cells: lessons from leukemia. Trends Cell Biol 15, 494-501 (2005) (Pubitemid 41253469)
6. Bonnet, D. & J.E. Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-7 (1997) (Pubitemid 27298715)
7. Barker, N. & H. Clevers: Leucine-rich repeat-containing Gprotein- coupled receptors as markers of adult stem cells. Gastroenterology 138, 1681-96 (2010)
8. Ricci-Vitiani, L., E. Fabrizi, E. Palio, & R. De Maria: Colon cancer stem cells. J Mol Med 87, 1097-104 (2009)
9. Todaro, M., M.G. Francipane, J.P. Medema, & G. Stassi: Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138, 2151-62 (2010)
10. Potten, C.S., R. Gandara, Y.R. Mahida, M. Loeffler, & N.A. Wright: The stem cells of small intestinal crypts: where are they? Cell Prolif 42, 731-50 (2009)
11. Bjerknes, M. and H. Cheng: Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology 116, 7-14 (1999) (Pubitemid 29013487)
12. Barker, N., J.H. van Es, J. Kuipers, P. Kujala, M. van den Born, M. Cozijnsen, A. Haegebarth, J. Korving, H. Begthel, P.J. Peters, & H. Clevers: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-7 (2007) (Pubitemid 350014593)
13. Sangiorgi, E. & M.R. Capecchi: Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 40, 915-20 (2008) (Pubitemid 351913652)
14. Boman, B.M., R. Walters, J.Z. Fields, A.J. Kovatich, T. Zhang, G.A. Isenberg, S.D. Goldstein, & J.P. Palazzo: Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol 165, 1489-98 (2004) (Pubitemid 39435149)
15. Dexter, D.L., E.N. Spremulli, Z. Fligiel, J.A. Barbosa, R. Vogel, A. VanVoorhees, & P. Calabresi: Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med 71, 949-56 (1981) (Pubitemid 12191976)
16. Marsh, K.A., G.W. Stamp, & S.C. Kirkland: Isolation and characterization of multiple cell types from a single human colonic carcinoma: tumourigenicity of these cell types in a xenograft system. J Pathol 170, 441-50 (1993) (Pubitemid 23253024)
17. Pierce, G.B., P.K. Nakane, A. Martinez-Hernandez, & J.M. Ward: Ultrastructural comparison of differentiation of stem cells of murine adenocarcinomas of colon and breast with their normal counterparts. J Natl Cancer Inst 58, 1329-45 (1977) (Pubitemid 8096299)
18. Blank, M., E. Klussmann, S. Kruger-Krasagakes, A. Schmitt-Graff, M. Stolte, G. Bornhoeft, H. Stein, P.X. Xing, I.F. McKenzie, C.P. Verstijnen, & et al.: Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 59, 301-6 (1994) (Pubitemid 24331817)
19. Grabowski, P., J. Schonfelder, G. Ahnert-Hilger, H.D. Foss, H. Stein, G. Berger, M. Zeitz, & H. Scherubl: Heterogeneous expression of neuroendocrine marker proteins in human undifferentiated carcinoma of the colon and rectum. Ann N Y Acad Sci 1014, 270-4 (2004) (Pubitemid 38594815)
20. West, A.B., C.A. Isaac, J.M. Carboni, J.S. Morrow, M.S. Mooseker, & K.W. Barwick: Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms. Gastroenterology 94, 343-52 (1988) (Pubitemid 18054769)
21. Korinek, V., N. Barker, P.J. Morin, D. van Wichen, R. de Weger, K.W. Kinzler, B. Vogelstein, & H. Clevers: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275, 1784-7 (1997) (Pubitemid 27136714)
22. Morin, P.J., A.B. Sparks, V. Korinek, N. Barker, H. Clevers, B. Vogelstein, & K.W. Kinzler: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-90 (1997) (Pubitemid 27136715)
23. van de Wetering, M., E. Sancho, C. Verweij, W. de Lau, I. Oving, A. Hurlstone, K. van der Horn, E. Batlle, D. Coudreuse, A.P. Haramis, M. Tjon-Pon-Fong, P. Moerer, M. van den Born, G. Soete, S. Pals, M. Eilers, R. Medema, & H. Clevers: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-50 (2002) (Pubitemid 35292444)
24. Van der Flier, L.G., J. Sabates-Bellver, I. Oving, A. Haegebarth, M. De Palo, M. Anti, M.E. Van Gijn, S. Suijkerbuijk, M. Van de Wetering, G. Marra, & H. Clevers: The Intestinal Wnt/TCF Signature. Gastroenterology 132, 628-32 (2007)
25. O'Brien, C.A., A. Pollett, S. Gallinger, & J.E. Dick: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-10 (2007) (Pubitemid 46067310)
26. Ricci-Vitiani, L., D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, & R. De Maria: Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-5 (2007) (Pubitemid 46067311)
27. Kunz-Schughart, L.A., M. Kreutz, & R. Knuechel: Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology. Int J Exp Pathol 79, 1-23 (1998) (Pubitemid 28137705)
28. Singh, S.K., C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano, & P.B. Dirks: Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004) (Pubitemid 39551674)
29. Chu, P., D.J. Clanton, T.S. Snipas, J. Lee, E. Mitchell, M.L. Nguyen, E. Hare, & R.J. Peach: Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer 124, 1312-21 (2009)
30. Feng, H.L., Y.Q. Liu, L.J. Yang, X.C. Bian, Z.L. Yang, B. Gu, H. Zhang, C.J. Wang, X.L. Su, & X.M. Zhao: Expression of CD133 correlates with differentiation of human colon cancer cells. Cancer Biol Ther 9, 216-23 (2010)
31. Shmelkov, S.V., J.M. Butler, A.T. Hooper, A. Hormigo, J. Kushner, T. Milde, R. St Clair, M. Baljevic, I. White, D.K. Jin, A. Chadburn, A.J. Murphy, D.M. Valenzuela, N.W. Gale, G. Thurston, G.D. Yancopoulos, M. D'Angelica, N. Kemeny, D. Lyden, & S. Rafii: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118, 2111-20 (2008) (Pubitemid 351872330)
32. Zhu, L., P. Gibson, D.S. Currle, Y. Tong, R.J. Richardson, I.T. Bayazitov, H. Poppleton, S. Zakharenko, D.W. Ellison, & R.J. Gilbertson: Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603-7 (2009)
33. Snippert, H.J., J.H. van Es, M. van den Born, H. Begthel, D.E. Stange, N. Barker, & H. Clevers: Prominin- 1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 136, 2187-2194 (2009)
34. Kemper, K., M.R. Sprick, M. de Bree, A. Scopelliti, L. Vermeulen, M. Hoek, J. Zeilstra, S.T. Pals, H. Mehmet, G. Stassi, & J.P. Medema: The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 70, 719-29 (2010)
35. Lin, E.H., M. Hassan, Y. Li, H. Zhao, A. Nooka, E. Sorenson, K. Xie, R. Champlin, X. Wu, & D. Li: Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 110, 534-42 (2007) (Pubitemid 47106141)
36. Artells, R., I. Moreno, T. Diaz, F. Martinez, B. Gel, A. Navarro, R. Ibeas, J. Moreno, & M. Monzo: Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer 46, 642-9 (2010)
37. Saigusa, S., K. Tanaka, Y. Toiyama, T. Yokoe, Y. Okugawa, Y. Ioue, C. Miki, & M. Kusunoki: Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 16, 3488-98 (2009)
38. Horst, D., L. Kriegl, J. Engel, T. Kirchner, & A. Jung: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 99, 1285-9 (2008)
39. Li, C.Y., B.X. Li, Y. Liang, R.Q. Peng, Y. Ding, D.Z. Xu, X. Zhang, Z.Z. Pan, D.S. Wan, Y.X. Zeng, X.F. Zhu, & X.S. Zhang: Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med 7, 56 (2009)
40. Horst, D., S.K. Scheel, S. Liebmann, J. Neumann, S. Maatz, T. Kirchner, & A. Jung: The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 219, 427-34 (2009)
41. Choi, D., H.W. Lee, K.Y. Hur, J.J. Kim, G.S. Park, S.H. Jang, Y.S. Song, K.S. Jang, & S.S. Paik: Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 15, 2258-64 (2009)
42. Du, L., H. Wang, L. He, J. Zhang, B. Ni, X. Wang, H. Jin, N. Cahuzac, M. Mehrpour, Y. Lu, & Q. Chen: CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14, 6751-60 (2008)
43. Al-Hajj, M., M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, & M.F. Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983-8 (2003) (Pubitemid 36418143)
44. Wielenga, V.J., R. Smits, V. Korinek, L. Smit, M. Kielman, R. Fodde, H. Clevers, & S.T. Pals: Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154, 515-23 (1999) (Pubitemid 29094101)
45. Kim, H., X.L. Yang, C. Rosada, S.R. Hamilton, and J.T. August: CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch Biochem Biophys 310, 504-7 (1994) (Pubitemid 24172699)
46. Kopp, R., M. Fichter, G. Schalhorn, J. Danescu, & S. Classen: Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas. Int J Mol Med 24, 677-83 (2009)
47. Mulder, J.W., V.J. Wielenga, M.M. Polak, F.M. van den Berg, G.R. Adolf, P. Herrlich, S.T. Pals, & G.J. Offerhaus: Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 36, 76-80 (1995)
48. Ropponen, K.M., M.J. Eskelinen, P.K. Lipponen, E. Alhava, & V.M. Kosma: Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol 33, 301-9 (1998) (Pubitemid 28156922)
49. Suh, S.I., W.K. Baek, J.W. Park, O.S. Bae, M.H. Suh, & B.K. Choe: Identification of CD44 splice variant in Korean colorectal cancers and cell lines. J Korean Med Sci 10, 169-75 (1995)
50. Takeuchi, K., A. Yamaguchi, T. Urano, T. Goi, G. Nakagawara, & H. Shiku: Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res 86, 292-7 (1995)
51. Dalerba, P., S.J. Dylla, I.K. Park, R. Liu, X. Wang, R.W. Cho, T. Hoey, A. Gurney, E.H. Huang, D.M. Simeone, A.A. Shelton, G. Parmiani, C. Castelli, & M.F. Clarke: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104, 10158-63 (2007) (Pubitemid 47175279)
52. Subramaniam, V., I.R. Vincent, M. Gilakjan, & S. Jothy: Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy. Exp Mol Pathol 83, 332-40 (2007) (Pubitemid 350087029)
53. Subramaniam, V., I.R. Vincent, H. Gardner, E. Chan, H. Dhamko, & S. Jothy: CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation. Exp Mol Pathol 83, 207-15 (2007) (Pubitemid 47320661)
54. Misra, S., V.C. Hascall, C. De Giovanni, R.R. Markwald, & S. Ghatak: Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE. J Biol Chem 284, 12432-46 (2009)
55. Patel, B.B., Y. Yu, J. Du, E. Levi, P.A. Phillip, & A.P. Majumdar: Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer. Biochem Biophys Res Commun 378, 344-7 (2009)
56. Levi, E., S. Misra, J. Du, B.B. Patel, & A.P. Majumdar: Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts. Biochem Biophys Res Commun 385, 430-3 (2009)
57. Weichert, W., T. Knosel, J. Bellach, M. Dietel, & G. Kristiansen: ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57, 1160-4 (2004) (Pubitemid 39486521)
58. Vermeulen, L., M. Todaro, F. de Sousa Mello, M.R. Sprick, K. Kemper, M. Perez Alea, D.J. Richel, G. Stassi, & J.P. Medema: Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105, 13427-32 (2008)
59. Fang, D.D., Y.J. Kim, C.N. Lee, S. Aggarwal, K. McKinnon, D. Mesmer, J. Norton, C.E. Birse, T. He, S.M. Ruben, & P.A. Moore: Expansion of CD133 (+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 102, 1265-75 (2010)
60. McKinnon, P.J., S.K. McLaughlin, M. Kapsetaki, & R.F. Margolskee: Extracellular matrix-associated protein Sc1 is not essential for mouse development. Mol Cell Biol 20, 656-60 (2000) (Pubitemid 30023107)
61. Horst, D., L. Kriegl, J. Engel, T. Kirchner, & A. Jung: Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest 27, 844-50 (2009)
62. Ginestier, C., M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, S. Liu, A. Schott, D. Hayes, D. Birnbaum, M.S. Wicha, & G. Dontu: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-67 (2007) (Pubitemid 350056407)
63. Huang, E.H., M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J.Z. Fields, M.S. Wicha, & B.M. Boman: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69, 3382-9 (2009)
64. Deng, S., X. Yang, H. Lassus, S. Liang, S. Kaur, Q. Ye, C. Li, L.P. Wang, K.F. Roby, S. Orsulic, D.C. Connolly, Y. Zhang, K. Montone, R. Butzow, G. Coukos, & L. Zhang: Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5, e10277 (2010)
65. Carpentino, J.E., M.J. Hynes, H.D. Appelman, T. Zheng, D.A. Steindler, E.W. Scott, & E.H. Huang: Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. Cancer Res 69, 8208-15 (2009)
66. Sladek, N.E.: Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. Curr Pharm Des 5, 607-25 (1999) (Pubitemid 29484992)
67. Marchitti, S.A., C. Brocker, D. Stagos, & V. Vasiliou: Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 4, 697-720 (2008) (Pubitemid 352003194)
68. Moreb, J.S., D. Mohuczy, B. Ostmark, & J.R. Zucali: RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. Cancer Chemother Pharmacol 59, 127-36 (2007) (Pubitemid 44796110)
69. Sreerama, L. & N.E. Sladek: Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Biochem Pharmacol 45, 2487-505 (1993) (Pubitemid 23189543)
70. Wroczynski, P., M. Nowak, J. Wierzchowski, A. Szubert, & J. Polanski: Activities of cytosolic aldehyde dehydrogenase isozymes in colon cancer: determination using selective, fluorimetric assays. Acta Pol Pharm 62, 427-33 (2005)
71. Doyle, L.A., W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, A.K. Rishi, & D.D. Ross: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95, 15665-70 (1998) (Pubitemid 29018757)
72. Ding, X.W., J.H. Wu, & C.P. Jiang: ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci 86, 631-7 (2010)
73. Zhou, S., J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath, J.J. Morris, I. Lagutina, G.C. Grosveld, M. Osawa, H. Nakauchi, & B.P. Sorrentino: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype. Nat Med 7, 1028-34 (2001) (Pubitemid 32937383)
74. Hirschmann-Jax, C., A.E. Foster, G.G. Wulf, J.G. Nuchtern, T.W. Jax, U. Gobel, M.A. Goodell, & M.K. Brenner: A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 101, 14228-33 (2004) (Pubitemid 39305058)
75. Haraguchi, N., T. Utsunomiya, H. Inoue, F. Tanaka, K. Mimori, G.F. Barnard, & M. Mori: Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24, 506-13 (2006) (Pubitemid 44464754)
76. Burkert, J., W.R. Otto, & N.A. Wright: Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 214, 564-73 (2008) (Pubitemid 351482271)
77. Liu, C., G. Zhao, J. Liu, N. Ma, P. Chivukula, L. Perelman, K. Okada, Z. Chen, D. Gough, & L. Yu: Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. J Control Release 140, 277-83 (2009)
78. Blokzijl, H., S. Vander Borght, L.I. Bok, L. Libbrecht, M. Geuken, F.A. van den Heuvel, G. Dijkstra, T.A. Roskams, H. Moshage, P.L. Jansen, & K.N. Faber: Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis 13, 710-20 (2007) (Pubitemid 46909985)
79. Gupta, P.B., T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R.A. Weinberg, & E.S. Lander: Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell 138, 645-59 (2009)
80. Riccioni, R., M.L. Dupuis, M. Bernabei, E. Petrucci, L. Pasquini, G. Mariani, M. Cianfriglia, & U. Testa: The cancer stem cell selective inhibitor salinomycin is a pglycoprotein inhibitor. Blood Cells Mol Dis 45, 86-92 (2010)
81. Uchida, H., K. Yamazaki, M. Fukuma, T. Yamada, T. Hayashida, H. Hasegawa, M. Kitajima, Y. Kitagawa, & M. Sakamoto: Overexpression of leucine-rich repeatcontaining G protein-coupled receptor 5 in colorectal cancer. Cancer Sci 101, 1731-1737 (2010)
82. Sato, T., R.G. Vries, H.J. Snippert, M. van de Wetering, N. Barker, D.E. Stange, J.H. van Es, A. Abo, P. Kujala, P.J. Peters, & H. Clevers: Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche. Nature 459, 262-5 (2009)
83. Barker, N., R.A. Ridgway, J.H. van Es, M. van de Wetering, H. Begthel, M. van den Born, E. Danenberg, A.R. Clarke, O.J. Sansom, & H. Clevers: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-11 (2009)
84. McClanahan, T., S. Koseoglu, K. Smith, J. Grein, E. Gustafson, S. Black, P. Kirschmeier, & A.A. Samatar: Identification of overexpression of orphan G proteincoupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol Ther 5, 419-26 (2006)
85. Becker, L., Q. Huang, & H. Mashimo: Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. Scientific World Journal 8, 1168-76 (2008)
86. Morita, H., S. Mazerbourg, D.M. Bouley, C.W. Luo, K. Kawamura, Y. Kuwabara, H. Baribault, H. Tian, & A.J. Hsueh: Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension. Mol Cell Biol 24, 9736-43 (2004) (Pubitemid 39458802)
87. Weichert, W., C. Denkert, M. Burkhardt, T. Gansukh, J. Bellach, P. Altevogt, M. Dietel, & G. Kristiansen: Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 11, 6574-81 (2005) (Pubitemid 41338997)
88. Fujimoto, K., R.D. Beauchamp, & R.H. Whitehead: Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression. Gastroenterology 123, 1941-8 (2002) (Pubitemid 35408318)
89. Strater, J., U. Wedding, T.F. Barth, K. Koretz, C. Elsing, & P. Moller: Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells. Gastroenterology 110, 1776-84 (1996) (Pubitemid 26169215)
90. Kirkland, S.C.: Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br J Cancer 101, 320-6 (2009)
91. Herlyn, D., M. Herlyn, Z. Steplewski, & H. Koprowski: Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol 9, 657-9 (1979) (Pubitemid 10225217)
92. Went, P., M. Vasei, L. Bubendorf, L. Terracciano, L. Tornillo, U. Riede, J. Kononen, R. Simon, G. Sauter, & P.A. Baeuerle: Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 94, 128-35 (2006) (Pubitemid 43088552)
93. Maetzel, D., S. Denzel, B. Mack, M. Canis, P. Went, M. Benk, C. Kieu, P. Papior, P.A. Baeuerle, M. Munz, & O. Gires: Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 11, 162-71 (2009)
94. Gosens, M.J., L.C. van Kempen, C.J. van de Velde, J.H. van Krieken, & I.D. Nagtegaal: Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol 20, 221-32 (2007) (Pubitemid 46422177)
95. van der Flier, L.G., M.E. van Gijn, P. Hatzis, P. Kujala, A. Haegebarth, D.E. Stange, H. Begthel, M. van den Born, V. Guryev, I. Oving, J.H. van Es, N. Barker, P.J. Peters, M. van de Wetering, & H. Clevers: Transcription factor achaete scutelike 2 controls intestinal stem cell fate. Cell 136, 903-12 (2009)
96. van der Flier, L.G., A. Haegebarth, D.E. Stange, M. van de Wetering, & H. Clevers: OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137, 15-7 (2009)
97. Conrotto, P., C. Roesli, J. Rybak, P. Kischel, D. Waltregny, D. Neri, & V. Castronovo: Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int J Cancer 123, 2856-64 (2008)
98. Koshida, S., D. Kobayashi, R. Moriai, N. Tsuji, & N. Watanabe: Specific overexpression of OLFM4 (GW112/HGC- 1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98, 315-20 (2007) (Pubitemid 46195600)
99. Liu, W., Y. Liu, J. Zhu, E. Wright, I. Ding, & G.P. Rodgers: Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin Cancer Res 14, 1041-9 (2008) (Pubitemid 351302549)
100. Tateishi, K., M. Ohta, F. Kanai, B. Guleng, Y. Tanaka, Y. Asaoka, M. Tada, M. Seto, A. Jazag, L. Lianjie, M. Okamoto, H. Isayama, H. Yoshida, T. Kawabe, & M. Omata: Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res 12, 6960-6 (2006) (Pubitemid 44974489)
101. Du, J., Y. Li, J. Li, & J. Zheng: Polycomb group protein Bmi1 expression in colon cancers predicts the survival. Med Oncol (2009)
102. Kayahara, T., M. Sawada, S. Takaishi, H. Fukui, H. Seno, H. Fukuzawa, K. Suzuki, H. Hiai, R. Kageyama, H. Okano, & T. Chiba: Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett 2003 535, 131-5 (2003) (Pubitemid 36126368)
103. Potten, C.S., C. Booth, G.L. Tudor, D. Booth, G. Brady, P. Hurley, G. Ashton, R. Clarke, S. Sakakibara, & H. Okano: Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 71, 28-41 (2003) (Pubitemid 38230417)
104. Sureban, S.M., R. May, R.J. George, B.K. Dieckgraefe, H.L. McLeod, S. Ramalingam, K.S. Bishnupuri, G. Natarajan, S. Anant, & C.W. Houchen: Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology 134, 1448-58 (2008)
105. Segal, N.H. & L.B. Saltz: Evolving treatment of advanced colon cancer. Annu Rev Med 60, 207-19 (2009)
106. Aguirre-Ghiso, J.A.: Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7, 834-46 (2007) (Pubitemid 350006258)
107. Quesnel, B.: Tumor dormancy and immunoescape. APMIS 116, 685-94 (2008)
108. Dallas, N.A., L. Xia, F. Fan, M.J. Gray, P. Gaur, G. van Buren, 2nd, S. Samuel, M.P. Kim, S.J. Lim, & L.M. Ellis: Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulinlike growth factor-I receptor inhibition. Cancer Res 69, 1951-7 (2009)
109. Yu, Y., S.S. Kanwar, B.B. Patel, J. Nautiyal, F.H. Sarkar, & A.P. Majumdar: Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Transl Oncol 2, 321-8 (2009)
110. Todaro, M., M.P. Alea, A.B. Di Stefano, P. Cammareri, L. Vermeulen, F. Iovino, C. Tripodo, A. Russo, G. Gulotta, J.P. Medema, & G. Stassi: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389-402 (2007) (Pubitemid 47506537)